Data on who is dying, when they are dying, and what they are dying from are crucial for identifying vulnerable populations and targeting health interventions, as well as for resource planning and ...

The Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) is a cornerstone in global health research and the ...

Discover BioVie's latest clinical advancements in Parkinson's, long COVID, and ascites. Learn about investment potential and upcoming data readouts.

On November 4, 2024, Karolinska Institutet (KI) hosted the symposium "Beyond Amyloid and Tau: The Importance of ...

Faeth Therapeutics is a clinical-stage biotechnology company integrating targeted therapies with precision nutrition interventions to exploit metabolic vulnerabilities in cancer. Founded by renowned ...

President Trump is expected to sign a TikTok deal this week that would give American investors majority control and allow a US-based company to safeguard users’ data, a senior White House official ...

High dose rezpegaldesleukin achieved statistical significance on multiple patient-reported outcome assessments at completion of 16-week induction period Interim data presented for patients who ...

SYMPHONY-PE Trial Demonstrated Strong Efficacy, Efficiency, and Safety Results with No Mortality and No Device-Related Serious Adverse Events In the trial, Symphony demonstrated a strong safety ...

CAMPBELL, Calif.--(BUSINESS WIRE)--Imperative Care, Inc. today announced positive efficacy and safety results from the pivotal SYMPHONY-PE Trial (NCT06062329) evaluating the company’s Symphony® ...

Imperative Care Announces Late-Breaking Data Presentation and Peer-Reviewed Publication from Pivotal Trial of Symphony Thrombectomy System in Patients with Acute Pulmonary Embolism SYMPHONY-PE ...

Across both STOP-HS1 and STOP-HS2, povorcitinib treatment resulted in continued clinically meaningful and statistically significant improvements for patients with active moderate to severe ...

Mechanical thrombectomy offers a promising alternative to thrombolytic-based approaches for reducing thrombus burden and right heart strain in acute pulmonary embolism. This pivotal Food and Drug ...